chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bouts of high anxiety; Exhausted; Aching body; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 06Oct2023 at 10:30 as dose 1, single (Lot number: HG4665) at the age of 48 years, in left arm for covid-19 immunisation; for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VENLAFAXINE; FAMOTIDINE; PANTOPRAZOLE; ATORVASTATIN. The following information was reported: PAIN (non-serious) with onset 07Oct2023 at 18:00, outcome "not recovered", described as "Aching body"; ANXIETY (non-serious) with onset 07Oct2023 at 18:00, outcome "not recovered", described as "Bouts of high anxiety"; DIARRHOEA (non-serious) with onset 07Oct2023 at 18:00, outcome "not recovered", described as "Diarrhea"; FATIGUE (non-serious) with onset 07Oct2023 at 18:00, outcome "not recovered", described as "Exhausted". Therapeutic measures were not taken as a result of anxiety, fatigue, pain, diarrhoea.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
adult patient received a pediatric dose / on 21-Jan-2021 and a second pediatric dose / in 21-Feb-2021; adult patient received a pediatric dose / on 21-Jan-2021 and a second pediatric dose / in 21-Feb-2021; adult patient received a pediatric dose / on 21-Jan-2021 and a second pediatric dose; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 57-year-old female patient who received HAV (Havrix pediatric) for prophylaxis.   Concomitant products included HAV (Havrix pediatric).   On 21st February 2021, the patient received the 2nd dose of Havrix pediatric (intramuscular). On 21st February 2021, unknown after receiving Havrix pediatric, the patient experienced underdose, adult use of a child product and drug dose administration interval too short. On an unknown date, the outcome of the underdose, adult use of a child product and drug dose administration interval too short were unknown.  Additional details were provided as follows: The pharmacist reported that an adult patient received a pediatric dose of Havrix, which led to underdose, adult use of a child product and shortening vaccinations schedule. The reporter mentioned that, both doses were given intramuscularly. The reporter consented to follow up. This case linked with US2021142825, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021142825:Same reporter
Hurts; red bump approximately a little bigger than a quarter on the injection site; red bump approximately a little bigger than a quarter on the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (Hurts), VACCINATION SITE SWELLING (red bump approximately a little bigger than a quarter on the injection site) and VACCINATION SITE ERYTHEMA (red bump approximately a little bigger than a quarter on the injection site) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Hurts), VACCINATION SITE SWELLING (red bump approximately a little bigger than a quarter on the injection site) and VACCINATION SITE ERYTHEMA (red bump approximately a little bigger than a quarter on the injection site). At the time of the report, VACCINATION SITE PAIN (Hurts), VACCINATION SITE SWELLING (red bump approximately a little bigger than a quarter on the injection site) and VACCINATION SITE ERYTHEMA (red bump approximately a little bigger than a quarter on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.   Reporter did not allow further contact
Patient was given Diluent, but was not reconstituted with 2nd vial of powder. Called company hotline. Patient with no adverse symptoms or outcome.
Information has been received from a physician concerning a 4 year old male with no pertinent medical history and no drug reactions/allergies, who was vaccinated with a second 0.5 mL dose of VARIVAX (Merck). There was no concomitant medication. On approximately 25-MAR-2008 the patient after receiving the vaccine experienced a fever. No further information was provided. There were no lab diagnostic studies performed. Unspecified medical attention was sought. The outcome was reported as recovered. There was no product quality complaint. Additional information is not expected. The reporting physician is unable to identify the patient.
Achiness; Tired; lymph nodes were swollen; tingling and numbing kind of feeling; arm feels kind of swollen; tingling and numbing kind of feeling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 09:30 (Batch/Lot number: unknown) at the age of 53 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Brand; Pfizer BioNTech, Dose=1, Location: right arm), administration date: 04Feb2021, when the patient was 53 years old, for Covid-19 Immunisation. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Achiness"; FATIGUE (non-serious), outcome "unknown", described as "Tired"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "lymph nodes were swollen"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious), outcome "unknown" and all described as "tingling and numbing kind of feeling"; PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "arm feels kind of swollen". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: Caller reported that she received the second dose of the Covid-19 Vaccine on Thursday 25Feb2021 at about 09:30. She had some symptoms for about 30 hours afterward that she said that she expected like the achiness and tired. On Friday evening, her lymph nodes were swollen under her left arm. That is where she got her shot, the left arm. Every day since since it is swollen, puffy, and painful to touch. She said that it is all the way down her arm, from her hand into her fingers, like a tingling and numbing kind of feeling that is uncomfortable. She got up this morning and when she stretched her arm up, she feels from her armpit to her elbow it feels like it will rip. Her skin feels like it is going to rip even when she turns, moves or twists her arm. She said that it is a uncomfortable feeling on the inside of her arm. Caller does not have the email address or address for the primary care physician to provide. She said that her first dose was in the right arm. Caller asked, does she need to worry about any of these symptoms since it is getting worse and not better?
Developed peeling palms bilaterally which progressed to complete desquamation of the palms. He also developed tingling paresthesias in the fingertips of the rt hand (side of injection).
At 8:30 AM on 4-5-21, my entire body broke out into a horrible rash
Initial report was received from a health care professional on 23 January 2012. A 3-year-old male patient had received an intramuscular dose 2 injection of FLUZONE, sanofi pasteur Inc., lot number UH467AA (site of administration unknown) on 05 December 2011. The reporter reported that the patient's adverse events started on 22 December 2011. On 04 January 2012, the patient was limping, had complaints of everything hurting and went to the emergency room (ER) for bacterial pharyngitis and continued antibiotics. On 07 January 2012, the patient was limping and had unsteady gait and was hospitalized for Guillain-Barre Syndrome (GBS) on 11 January 2012. Illness at the time of vaccination and concomitant medications were reported as none. The patient had no known allergies (NKA). No adverse events to prior vaccinations were reported. The patient had previously received an influenza vaccination. No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: none.
Pt got the shot (ZOSTAVAX) on 7/27/15 and came in 7/30/15 stated her injection site about half dollar size, tender was red, achy. Pt took ibuprofen, I told her to contact MD if it doesn't go away. Spoke to pt on 8/2-she is okay.
tenderness redness induration 1.5" diameter at injection site       not needing any intervention
sudden flushing of upper body starting around 4PM 3/6/21 - about 50 hrs post-dose - took Benadryl 50mg seemed to diminish some 30-40 minutes later - itch gone, still minor redness on upper chest, shoulders and face
Patient received refrigerated vial of vaccine 16 hours after first puncture. Vial punctured 6/1/2021 at  2:20pm; drawn and administered 6/2/2021 at 9:25am Exp date of vaccine: 6/23/2021
After 11 days post booster vaccine I started notice hives that were all over my body mostly noticed them around straps, bra lines, and my skin was really reactive to any abrasions and would cause hives to form at site. Itchiness around shirt collars, I took Benadryl  and Allegra for about 2 months and now I can get by with taking one Allegra once daily and occasionally Benadryl if I get itchy. My hives are not as severe as before however if I am late to taking the Allegra I will have a worse reaction to the abrasions and hives forming than if I take it regularly. Spoke with Doctor and stated that I should continue taking Allegra. This does not deter me from taking another booster shot with symptoms.
pt recv vax 29APR98 & broke out in a rash all over body w/sl fever & lymph node enlargement 2wk p/vax;pt went to PMD & told this was the 1st case had seen a rxn from rubella in an adult;pt stayed off work 1wk because of appearance;
I received Dose 1 on Saturday, March 27th.  A week after getting the first dose,  (Sunday, April 4), I was dying the roots of my hair (with the same product and color I have been using the whole pandemic), and it tingled a little (which was slightly unusal,  but I didn't think much of it.). When I went to get in the shower to rinse my hair, on my left arm at the vaccine injection site there was a perfectly red triangle (slightly raised, warm to the touch).  On Monday (4/5) it spread a little big and got bigger, and today (4/6) it's definitely larger.  It doesn't hurt.  The spot is slightly hard (like a deep contustion would be).  I also have pictures if there is a way to send those please let me know.  I spoke with my doctor this morning and she has instructed me to being a benedryl regiment for now and check back with her in a couple of days.
Flu like symptoms, chills, body aches, headache, nausea, no energy, hit all of a sudden.  No fever, no appetite
arm soreness, fatigue, chills, body aches, 1/12-local swelling, redness, warm to the touch, heavy arms Narrative:
Today marks the ninth day of my second shot. I am still in extreme pain when I stretch or move it in the wrong way. The pain is localized around the injection site. It is a extremely sharp pain, it feels like the muscle is dead. The only treatment I have been using is medicated topical pads.
Severe cluster headaches and developed symptoms of polycystic ovary syndrome beginning from February 2015. From May 2015 to October 2015 developed short term memory loss, vitamin D2 deficiency, rapid weight gain of 70+ lbs despite diet and exercise, and began to pass out. Developed benign heart murmur August 2015. Moderate to severe joint pain, starting June 2015 continuing to present. Hypermobility diagnosed Feb 2017. Pelvic prolapse stage 2 and PCOS diagnosed June 2017. GYN suspects Ehlers Danlos syndrome and in process of testing. Working with nutritionist 1year, endocrinologist, GI, and rheumatology for 2 years. Referred to genetics clinic to test for presence and activation of EDS gene.
Magnetic clip sticking on injection site; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Magnetic clip sticking on injection site) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced VACCINATION SITE REACTION (Magnetic clip sticking on injection site) and PYREXIA (Fever). At the time of the report, VACCINATION SITE REACTION (Magnetic clip sticking on injection site) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) high.         Patient has allergies with poison .  No concomitant medications were reported. No treatment medication medications were reported.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 72-year-old female patient who received SHINGRIX. Concomitant products included Aspirin (Baby), Vitamin C and BENADRYL. On 9th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 9th April 2018, less than a day after receiving SHINGRIX, the patient experienced injection site erythema, injection site warmth and injection site itching. On an unknown date, the outcome of the injection site erythema, injection site warmth and injection site itching were recovering/resolving. The reporter considered the injection site erythema, injection site warmth and injection site itching to be related to SHINGRIX. Additional information was received as follows: Concomitant medication also included Vitamin D and Multivitamin. The patient reported that she received the SHINGRIX vaccine on the right arm last Monday and later that day she experienced redness at the injection site. The patient stated that the site was hot and there was itching at the site as well. The patient reported that the next day, the redness had grown to a 4 inch square. The patient stated that she used BENADRYL spray and that had helped. The patient stated that she was not sure if she would receive the 2nd dose. The patient had denied permission to contact their physician.
Member vaccinated 2/26/2003 one week later lesion on leg. Was given medication diagnosed as "spider bite".    In May, member developed similar lesion on upper knee, also diagnosed by PCP as spider bite.July, member over a four day time span develops another lesion approx 2.5 in circular indurated reddened with 1 in crusted center. Unknown etiology referred to ID and or Dermatology. Member has complaints of severe fatigue, pain, muscle spasms, anxiety, chest pain. Now reportslump at injection site Left arm.  Patient states he is not getting any better.
4JAN97 itchy, individual bumps, no discoloration;5JAN97 redness but less itching today;
Sore arm for over 6 weeks. Soreness going away now around 12/10/2020
on 8/25/23 - pt called in with moderate pain. No OTC taken as pt did not want to mask reaction ssx.  on 8/28/23 - pt seen with L deltoid erythema- arm is warm to touch and very painful (fire sensation)  - Tylenol, Aleve, Ice does not improve. No ssx of infection and defer ABX - to continue Tylenol/NSAID, Ice, and Benadryl.
Client verbalized feeling hot and flustered.  Client denies other symptoms.  Client seen and assessed by EMT and VS are BP 150/98, HR 74, O2Sat 98%.  Client verbalized that he was ok and felt no need for further evaluation and cleared to go home by EMT.
Temp of 103.1 a few hrs after getting vaccines. Given Ibuprofen by his mother.
Likely measles rash after vaccine. Rash started on face, then spread to back and stomach.
I was 22 weeks along with my third pregnancy (second viable) and my due date is 8/8/21. I received the Pfizer vaccine on Thursday, April 8, 2021. On Friday, April 9, around 1pm, I began to feel a lot of fatigue, slight body aches and started to come down with a slight fever of 99 degrees F. I called my OBGYN doctor's office to see if they would recommend I begin taking the Tylenol I already had on hand just in case I started to have a fever and they said to go ahead and take it (2 capsules every 6 hours as needed). After taking the first two capsules at 2pm and the first six hours had passed, I took another 2 capsules and checked my temperature again. This time it was at 100.6 (my doctor said a fever starts at 100.1). I continued to monitor my temperature every couple of hours and it went back down quickly and never came up again while I was taking the Tylenol (I took the capsules around 2pm, 8pm. The body aches also subsided, but the fatigue continued. I took my last 2 Tylenol capsules around 3am on Saturday, April 10, 2021.  On Saturday, I only felt slightly fatigued and much better than Friday and by Sunday, I was fine.
Numbness in shoulder, arm, and face. Symptoms started within 20 minutes and lasted for approximately two days.
Vomiting, body aches, weakness, confusion, headache urinating frequently,  fever 101.1 entire day following vaccine. Took Tylenol alternating with ibuprofens
"Normal" reaction of headache, body aches and nausea for 2-3 days. But, I believe that the vaccination cause the worst flair I have ever had with my rheumatoid arthritis. I was unable to walk or get up from a seated position on my own. The pain is now being treated with a prednisone taper for 12 days.
Swelling, redness, itchy, slight pain area at 5" x 3".
Case number PHEH2015US026896, is an initial spontaneous report received from a nurse on 22 Dec 2015. This report refers to a 24-year-old male patient. Medical history was not reported. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1514501, expiry date: May 2016) into left deltoid on 26 Oct 2015. It was reported that FLUVIRIN administered to the patient had a temperature excursion of 34 degrees. The nurse stated that, the reason was unknown for the refrigerator to be out of temperature range. There was no any further problem since the temperature excursion problem. No further information was provided. No adverse event was reported following this medication error. Follow up reported received from nurse on 26 Jan 2016: Updated reporters comments.
Patient had flu shot 10/23/02 in left arm. Pt came in on Saturday 10/26/02 with massive hematoma from shoulder to elbow. This hematoma did not appear until thursday evening as per pt.  I referred pt immediately to family doctor. Doctor said artery was nicked. I contacted Health Events on Saturday and also gave pt's doctor the info, as well as the pt. I contacted the visiting nurse association and the Wyeth Drug company.
The patient was presented to the vaccination site on 11/09/21. The client notified RN  that after her first dose of the COVID Moderna vaccine on 1/16/21 client reported feeling dizzy after an hour from getting vaccine. Client stated that the dizziness lasted about an hour. Client also stated that after her second dose of the COVID Moderna vaccine on 2/13/21 she also experienced the same symptom of dizziness but this time it was only for 30 minutes. RN  submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Moderna booster dose. Approval to proceed with COVID vaccine Moderna booster dose was obtained from medical consult team, Vaccine Operations Lead , RN via text message. Client received COVID vaccine Moderna booster dose Lot# 066F21A on 11/09/2021. The client did not report any symptoms during the 30 minute observation period. The client left the vaccination site at 1505 unassisted with a steady gait. Clients boyfriend stated that he would drive her home. RN  educated client on worsening signs and symptoms of receiving booster Moderna COVID vaccine and when to seek EMS, urgent care, or go to the ED. Client verbalized understanding.
Around 3/10/2021, I started to notice missed heart beats. Those episodes became more frequent with SOB. I was getting them multiple times a day in addition to chest discomfort and generalized pain. I have a nursing background and notice it is ventricular in nature. Around the 1st week of April 2021, I consulted with a cardiologist and did an EKG, Stress test, ECHO and Holter monitor. The Holter monitor confirms multiple v-tach. I was prescribed a Metoprolol and Verapamil. I am being referred to an electrophysiologist and I have been out of work since 6/9/2021. Even with the new medications, I am still having cardiac issues and tachycardia.
Approximately 1 1/2 to 2 hours after the shot, my mouth started to feel funny and slightly numb. My heart felt like it was fluttering and I felt weak and tired. I laid down and the symptoms continued with a tingling sensation, especially in my left arm, very slight tightness in my chest, and very cold feeling coursing through my limbs and body.  My heart felt like it was racing. The following day I felt weak, like my blood pressure was low though I didn't check it. I was tired, dizzy the following day with frequent fluttering heart feelings. I had a headache for a few days following.
Information has been received from a consumer concerning her husband who in approximately 1970, was vaccinated with MMR II. The consumer reported that her husband had febrile convulsions and paralysis after receiving the vaccine as a child in the 1970's. The patient's outcome was unknown. Upon internal review, paralysis and febrile convulsions were determined to be an other important medical events. Additional information has been requested.
This is a spontaneous report from a contactable physician assistant communicated to a sales representative report similar events for four patients. This is the 3rd of four reports. A patient of unspecified age ethnicity and gender received TRUMENBA, intramuscular at 0.5 ml, single on an unspecified date. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced chills/rigors, high fever and achy all over that required hospitalization. The outcome of the events was unknown. No follow-up attempts possible. No further information expected.
Patient developed febrile illness (rhinorhea, cough) with temperatures 103- 105. Requiring 2 visits with PCP and one urgent care
Client had a vasovagal response approx. 10minutes after receiving the vaccine.  Client's mother reported that the client was in the standing position when she became pale, eyes rolled back and she fell to the floor and lost consciousness for a few seconds.
day after booster had nerve pain on both arms and neck going up to head on  left side where I got shot, intense itching and soreness under left arm but no redness, arm injections site  soreness but not as bad as second Moderna shot, severe back pain, nausea, chills, muscle and joint pain,  finger pain, inability to sleep due to pain everywhere. A little better at the moment. hope no permanent damage from this booster long term. Do not have a doctor.